Eduardo Tolosa Sarró, MD, PhD
Professor of Neurology and Director of the Parkinson Disease Research IDIBAPS at University of Barcelona, Spain
Senior Consultant in the Parkinson Disease and Movement Disorder Unit at Hospital Clinic Universitari de Barcelona
Location: Barcelona, Spain
Eduardo Tolosa, MD, PhD earned his MD degree from the University of Barcelona, Spain, and obtained his neurological training at the University of Minnesota Hospital in Minneapolis. He was visiting scientist at Brookhaven National Hospital, where he worked with George Cotzias during 1974 and 1975, and, subsequently, he joined the faculty of the Department of Neurology at the University of Minnesota. He was later appointed chief of neurology at the University Hospital in Barcelona in 1982.
Prof. Tolosa was certified as a neurologist by the American Board of Neurology and Psychiatry in 1976 and became a fellow in 1997. He is a fellow of the American Academy of Neurology, the American Neurological Association and the Royal College of Physicians, and a founding member of the Movement Disorder Society (MDS). He has been president of the MDS and president of the European Neurological Society. Prof. Tolosa is an honorary member of several neurological societies, including the British Neurological Association and the French Neurological Society.
Prof. Tolosa’s research interests have centered on movement disorders and particularly in issues related to experimental therapeutics, etiology and pathophysiology of various parkinsonisms. His team has investigated the clinical and molecular genetics of Parkinson’s disease and progressive supranuclear palsy. In the areas of experimental therapeutics, Prof. Tolosa was involved in pioneer studies defining mechanisms underlying levodopa-related motor fluctuations, both in patients and in pre-clinical models of parkinsonism. His team has been among the first in Europe to evaluate efficacy of novel surgical strategies for Parkinson’s disease such as subthalamic nucleus stimulation and its impact upon patients cognition and quality of life. In addition, during the last years, he has dedicated his investigations to the study of the asymptomatic individuals carrying PD-causative mutations in the LRRK2 gene.